> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Feds Sue Firm Selling Unapproved Drugs
- URL: https://www.fdaweb.com/feds-sue-firm-selling-unapproved-drugs/
- Published: 2020-12-07T12:00:00.000Z
- Updated: 2026-09-14T16:39:11.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5148240

The Justice Department has filed a civil complaint to stop AMARC Enterprises from distributing unapproved and misbranded drugs and adulterated animal drugs. The company sold and distributed “Poly-MVA” and “Poly-MVA for Pets,” which they claim can cure, mitigate, treat, or prevent disease, including cancer. The complaint also alleges that the defendants intend for Poly-MVA to be administered intravenously. FDA has previously warned the company to stop making such claims, according to a [Justice release](https://www.justice.gov/opa/pr/justice-department-files-complaint-stop-distribution-unapproved-misbranded-and-adulterated?ref=fdaweb.com).  

The complaint contends that disease claims the company is making lack support from published, adequate, and well-controlled clinical studies. It also says that because Poly-MVA’s labeling does not have adequate directions for lay users, the product is misbranded.